vic3308

º²É­ÖÆÒ© º²É­ÖÆÒ©

ά¶àÀûÑÇÀÏÆ·ÅÆvic3308(Öйú)¹É·ÝÓÐÏÞ¹«Ë¾ ¼ò ¤™
  • ¼ò
  • ·±
  • EN
¤œ
Ïà¹ØÁ´½Ó
  • vic3308¥Y
ά¶àÀûÑÇÀÏÆ·ÅÆvic3308(Öйú)¹É·ÝÓÐÏÞ¹«Ë¾
ÐÂÎÅÐû²¼
Press Release
Ê×Ò³  >  ÐÂÎÅÖÐÐÄ  >  ÐÂÎÅÐû²¼
º²É­ÖÆÒ©Ðû²¼ÓëNiKang Therapeutics¹«Ë¾¾ÍÒ»¿îÐÂÐÍ¿¹²¡¶¾Ò©ÎïµÄ¿ª·¢¸æ¿¢ÏàÖú¹ØÏµ
Ðû²¼ÈÕÆÚ£º2020/04/24
×ÖºÅ

2020Äê4ÔÂ23ÈÕ£¬£¬ £¬£¬£¬£¬£¬£¬ÖйúÉϺ£ºÍÃÀ¹úÍþÃ÷¶ÙÊСª¡ªº²É­ÖÆÒ©(3692:HK)ºÍNiKang Therapeutics¹«Ë¾½ñÈÕÐû²¼£¬£¬ £¬£¬£¬£¬£¬£¬Ë«·½¾ÍÒ»¿îÁÙ´²Ç°Ð¡·Ö×Ó¿¹²¡¶¾Ò©ÎïNKT-1992ÔÚ´óÖлªÇø£¨Öк£Äڵء¢Ì¨Íå¡¢Ïã¸ÛºÍ°ÄÃÅ£©µÄ¿ª·¢ºÍÉÌÒµ»¯¸æ¿¢ÏàÖú¹ØÏµ¡£¡£¡£¡£¡£


        NKT-1992ÊÇ»ùÓڽṹÉè¼Æ£¬£¬ £¬£¬£¬£¬£¬£¬°ÐÏò¸ß¶ÈÊØ¾ÉµÄÃ¸ÇøÓò£¬£¬ £¬£¬£¬£¬£¬£¬¸ÃÇøÓò¹ØÓÚ²¡¶¾×ªÂ¼ºÍ¸´ÖÆÖÁ¹ØÖ÷Òª¡£¡£¡£¡£¡£ÒÖÖÆ¸Ã×÷ÓûúÖÆ½«Äܹ»¿ìËÙ½µµÍ²¡¶¾ÔØÁ¿ºÍÏà¹ØÖ¢×´¡£¡£¡£¡£¡£

 

¹ØÓÚÏàÖúµÄÏêÇ飬£¬ £¬£¬£¬£¬£¬£¬Çë²Î¿¼ÒÔϱ¨µÀ£º

https://www.businesswire.com/news/home/20200423005049/en/?from=timeline&isappinstalled=0

 


¹ØÓÚº²É­ÖÆÒ©


º²É­ÖÆÒ©(3692:HK)ÊÇÖйúÁìÏȵÄÉúÎïÖÆÒ©¹«Ë¾£¬£¬ £¬£¬£¬£¬£¬£¬ÖÂÁ¦ÓÚ¹Ø×¢Öª×ãÁÙ´²Î´¾¹µÄÒ½ÁÆÐèÇ󣬣¬ £¬£¬£¬£¬£¬£¬Ò»Á¬Ò»Ö±µØÍƳö¸ü¶àµÄÁ¢Òì²úÆ·£¬£¬ £¬£¬£¬£¬£¬£¬¸ÄÉÆÈËÀàµÄ¿µ½¡ºÍÉúÃüÖÊÁ¿¡£¡£¡£¡£¡£º²É­ÖÆÒ©ÏÖÔÚÔÚÖÐÃÀÓµÓÐÁè¼Ý9000ÃûÔ±¹¤¡£¡£¡£¡£¡£


¹«Ë¾½¨ÉèÓÚ1995Ä꣬£¬ £¬£¬£¬£¬£¬£¬¾ßÓÐ׿ԽµÄÑз¢ÊµÁ¦ÓëÁè¼Ý20 ÄêµÄÑз¢¡¢Éú²úºÍ²úÆ·ÉÌÒµ»¯ÂÄÀú£¬£¬ £¬£¬£¬£¬£¬£¬ÔÚÖÐÊàÉñ¾­ÏµÍ³¡¢¿¹Ö×Áö¡¢¿¹Ñ¬È¾¡¢ÌÇÄò²¡¡¢Ïû»¯µÀºÍÐÄѪ¹ÜµÈÁù´óÁìÓò¾ßÓÐÁìÏÈˮƽ¡£¡£¡£¡£¡£¹«Ë¾¾ßÓÐÁè¼Ý1200ÃûÑз¢Ö°Ô±£¬£¬ £¬£¬£¬£¬£¬£¬Í¨¹ý×ÔÖ÷Ñз¢£¬£¬ £¬£¬£¬£¬£¬£¬ÒѾ­ÀÖ³ÉÉÏÊÐ4¸ö1ÀàÁ¢ÒìÒ©¡£¡£¡£¡£¡£ÂõÁé´ï?£¨ÂðßøÏõßòÂÈ»¯ÄÆ×¢ÉäÒº£©ÊÇÈ«Çò40ÄêÀ´Ê׸öÏõ»ùßäßòÀ࿹ÑáÑõ¾úÁ¢ÒìÒ©Îï¡£¡£¡£¡£¡£æÚÀ´ÃÀ?£¨¾ÛÒÒ¶þ´¼ÂåÈûÄÇëÄ×¢ÉäÒº£©ÊÇÎÒ¹úÊ׸ö³¤Ð§GLP-1ÀཱུÌÇÒ©Î£¬ £¬£¬£¬£¬£¬£¬Ò²ÊÇÈ«ÇòµÚÒ»¿îPEG»¯µÄ³¤Ð§½µÌÇÒ©Î£¬ £¬£¬£¬£¬£¬£¬ÁÆÐ§Ã÷È·£¬£¬ £¬£¬£¬£¬£¬£¬Çå¾²ÐÔ¸ßÇÒÿÖܽöÐè×¢ÉäÒ»´Î¡£¡£¡£¡£¡£ºÀɭ꿸£?£¨¼×»ÇËá·úÂíÌæÄáÆ¬£©ÊÇÖйúÊ׸ö×ÔÖ÷Ñз¢µÄÐÂÐͶþ´úÂýÐÔËèϵ°×Ѫ²¡ÀࣨCML£©Á¢ÒìÒ©¡£¡£¡£¡£¡£°¢ÃÀÀÖ?£¨¼×»ÇËá°¢ÃÀÌæÄáÆ¬£©ÓÃÓÚÖÎÁÆ·ÇСϸ°û·Î°©£¬£¬ £¬£¬£¬£¬£¬£¬Îª3´úEGFRÒÖÖÆ¼Á£¬£¬ £¬£¬£¬£¬£¬£¬½â¾öT790MÄÍÒ©ÐÔÄÑÌ⣬£¬ £¬£¬£¬£¬£¬£¬ÑÓÐø»¼ÕßÉúÃü¡£¡£¡£¡£¡£


¹ØÓÚº²É­ÖÆÒ©µÄ¸ü¶àÐÅÏ¢£¬£¬ £¬£¬£¬£¬£¬£¬Çë»á¼ûwww.hspharm.com

 


¹ØÓÚNiKang Therapeutics¹«Ë¾


NiKang Therapeutics¹«Ë¾ÊÇÒ»¼Ò×ܲ¿Î»ÓÚÃÀ¹úÌØÀ­»ªÖÝÍþÃ÷¶ÙÊеÄÔçÆÚÉúÎïÒ½Ò©¹«Ë¾£¬£¬ £¬£¬£¬£¬£¬£¬ÖÂÁ¦ÓÚ·¢Ã÷ºÍ¿ª·¢Á¢ÒìÐÔС·Ö×Ó¿¹Ö×ÁöÒ©Î£¬ £¬£¬£¬£¬£¬£¬ÒÔÖª×ãÁÙ´²Î´¾¹µÄÐèÇ󡣡£¡£¡£¡£


¹«Ë¾µÄ°ÐµãÑ¡ÔñÒÔ¼²²¡ÉúÎïѧºÍ·Ö×ÓͨµÀΪÇý¶¯£¬£¬ £¬£¬£¬£¬£¬£¬¿ª·¢Õ½ÂÔÒ԰еã½á¹¹ÉúÎïѧºÍ»ùÓڽṹµÄÒ©ÎïÉè¼ÆÎª»ù´¡¡£¡£¡£¡£¡£¸ÃÑз¢Õ½ÂÔʹ¹«Ë¾Äܹ»¿ìËÙ¸ßЧµØ½«¾ßÓÐ×ÔÖ÷֪ʶ²úȨµÄºòѡҩÎïÍÆ½øÁÙ´²Ñз¢½×¶Î¡£¡£¡£¡£¡£


¹ØÓÚNiKang TherapeuticsµÄ¸ü¶àÐÅÏ¢£¬£¬ £¬£¬£¬£¬£¬£¬Çë»á¼ûhttp://nikangtx.com/

 

 

ÁªÏµ·½·¨

 

º²É­ÖÆÒ©:

Ͷ×ÊÕß¹ØÏµ£º

Sophia Dong

IR@hspharm.com

 

NiKang Therapeutics:

Business and Scientific Operation

Jessica Liu

Jessica.liu@nikangtx.com


ά¶àÀûÑÇÀÏÆ·ÅÆvic3308(Öйú)¹É·ÝÓÐÏÞ¹«Ë¾
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿